The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,404,747 in first-year total cost, median $530,098.
Most frequent study sections
- Cancer Biomarkers Study Section[CBSS]3
- Clinical Oncology Study Section[CONC]1
- Tumor Microenvironment Study Section[TME]1
Most frequent institutions
- MAYO CLINIC ROCHESTER3
- UNIVERSITY OF TX MD ANDERSON CAN CTR1
- WEILL MEDICAL COLL OF CORNELL UNIV1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Predicting clinical outcome in individuals with small CLL B cell clones1R01CA197120-01 | KAY, NEIL ESHANAFELT, TAIT D | MAYO CLINIC ROCHESTER, MN | $615,766 | CBSS |
| 2015 | The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma1R01CA194547-01 | ELEMENTO, OLIVIERTAM, WAYNE | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $530,098 | CBSS |
| 2015 | Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression1R01CA196831-01 | JELINEK, DIANE F | MAYO CLINIC ROCHESTER, MN | $363,713 | TME |
| 2014 | Protein-coding and non-coding RNA biomarkers for early detection of CLL1R01CA182905-01 | ABRUZZO, LYNNE V.CALIN, GEORGE A. | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $573,195 | CONC |
| 2014 | Prevalence and Progression of Monoclonal Gammopathies2R01CA107476-11 | KUMAR, SHAJI KUNNATHURAJKUMAR, S VINCENT | MAYO CLINIC ROCHESTER, MN | $321,975 | CBSS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.